Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 98Terminated 12Withdrawn 9Unknown 6Active not recruiting 6Recruiting 5Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Leukemia, Myeloid, Acute 1Hematologic Neoplasms 1

Interventions

fludarabine phosphate 2fludarabine 2Specimen Handling 2Melphalan 2Cyclophosphamide 2vactosertib 1azathiopurine 1aldesleukin 1Tacrolimus 1Stem Cell Transplantation 1Radiotherapy, Intensity-Modulated 1RFB4(dsFv)-PE38 recombinant immunotoxin 1Prednisolone 1Peripheral Blood Stem Cell Transplantation 1Mycophenolic Acid 1Methylprednisolone 1Mercaptopurine 1Magnetic Resonance Spectroscopy 1Leukapheresis 1Interleukin-2 1Imatinib Mesylate 1IL32 protein, human 1Health Promotion 1Educational Status 1Cytarabine 1Cetuximab 1Biopsy 1Antibodies, Monoclonal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Precursor Cell Lymphoblastic Leukemia-Lymphoma × Peripheral Blood Stem Cell Transplantation × Clear all
NCT02333162 2026-03-30

Intensity Modulated Total Marrow Irradiation, Fludarabine Phosphate, and Melphalan in Treating Patients With Relapsed Hematologic Cancers Undergoing a Second Donor Stem Cell Transplant

University of Chicago

Phase 1 Suspended
30 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡